Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma

Area of Science:

• Hepatology
• Immunology
• Toxicology

Background:

• Hepatocellular carcinoma (HCC) is a major global health concern.
• Hepatitis-B virus (HBV) infection is endemic in many populations and a known risk factor for HCC.
• Aflatoxins are known hepatotoxins and suspected carcinogens.

Purpose of the Study:

• To propose a novel mechanism for aflatoxin's role in hepatocellular carcinoma development.
• To investigate the indirect role of aflatoxin in HCC pathogenesis via immune modulation.

Main Methods:

• This study is based on postulating a new biological role for aflatoxin.
• The proposed mechanism involves the interaction between aflatoxin, cell-mediated immunity, and hepatitis-B virus persistence.

Main Results:

• Aflatoxin is postulated to suppress cell-mediated immunity, rather than acting as a primary carcinogen.
• This immune suppression facilitates the persistence of hepatitis-B virus in the liver.
• Chronic HBV infection and cirrhosis are suggested as intermediate steps to HCC.

Conclusions:

• Aflatoxin's primary role in human hepatocellular carcinoma may be indirect, through immunosuppression.
• This mechanism highlights the complex interplay between environmental toxins, viral infections, and immune status in liver cancer development.
• Targeting immune suppression could be a strategy to mitigate HCC risk in endemic regions.